Corona Virus Net is the web resource for anyone interested in Coronaviruses. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (COVID-19) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and humans. Common signs of infection include respiratory symptoms, fever, cough, and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Also avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.

A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO on 31 December 2019. The outbreak of COVID-19 was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO. As of March 11th, the WHO declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging that the virus will likely spread to all countries in the world.

The objectives of Corona Virus Net are to be the public and professional information resource for coronaviruses and to serve as a network in the exchange of information and news related to coronaviruses. What do you know about the novel Coronavirus that is causing a health emergency?

• WHO authorizes emergency use of Novavax's updated COVID shot - Reuters
  Tue, 28 Nov 2023 14:52 GMT
• New COVID-19 Hospitalizations Increase | Health News | U.S. News - U.S. News & World Report
  Mon, 27 Nov 2023 22:02 GMT
• Florida coronavirus cases, vaccines: State adds years of data after suit - Florida Today
  Mon, 27 Nov 2023 10:15 GMT
• OHSU coronavirus (COVID-19) response - OHSU News
  Tue, 28 Nov 2023 17:34 GMT
• Dallas Students Feel COVID-19 Effects in Chronic Absenteeism - Dallas Observer
  Tue, 28 Nov 2023 14:20 GMT
• Top White House health official says it's 'certainly possible' China KILLED researcher who started the Covid p - Daily Mail
  Tue, 28 Nov 2023 12:18 GMT
• Japan panel recommends approval of updated Daiichi Sankyo COVID shot- Kyodo - Reuters
  Mon, 27 Nov 2023 12:47 GMT
• Omicron, Now 2 Years Old, Is Not Done With Us Yet - The New York Times
  Tue, 21 Nov 2023 08:00 GMT
• Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate ... - Virology Journal
  Tue, 28 Nov 2023 16:48 GMT
• Slovakia moves away from daily coronavirus reports. Is it a problem? - The Slovak Spectator
  Mon, 27 Nov 2023 19:10 GMT
• Reported coronavirus cases rise in area, state | Local News ... - The Sun Chronicle
  Mon, 27 Nov 2023 02:00 GMT
• Situation Update #188 - Coronavirus Disease 2019 (COVID-19 ... - ReliefWeb
  Sun, 19 Nov 2023 08:00 GMT
• First bovine coronavirus vaccine hits UK - FarmersWeekly
  Tue, 28 Nov 2023 09:01 GMT
• Owensboro Health brings back mask requirement at several facilities - WEVV
  Tue, 28 Nov 2023 17:08 GMT
• Weekly COVID-19 cases up for sixth week: Coronavirus update for Wednesday, Nov. 22 - cleveland.com
  Wed, 22 Nov 2023 20:00 GMT

• PRO/AH/EDR> COVID-19 update (323): Pfizer vaccine in children, vaccine diplomacy, WHO
  Mon, 20 Sep 2021 21:44:10 -0400
  COVID-19 -- Worldwide/Unknown
  A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
  The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
  The companies still must

• Higher order neurocognition in pediatric brain tumor survivors: What can we learn from white matter microstructure? Tue, 28 Nov 2023 06:00:00 -0500
  CONCLUSIONS: PBTS demonstrate poorer neurocognitive functioning that is linked to differences in WM microstructure, as evidenced by higher diffusivity in the ACR, SLF, and IFOF. These findings support the use of MD in understanding alterations in WM microstructure in PTBS and shed light on potential functions of these pathways.
• Lung ultrasound evaluation in people with cystic fibrosis: A new approach in the pulmonology outpatient clinic Tue, 28 Nov 2023 06:00:00 -0500
  CONCLUSIONS: Our study describes LUS findings in pwCF. It also showed a correlation between LUS score and the patients' lung function measured by spirometric indices. We conclude that LUS may be useful in routine monitoring of pwCF in combination with clinical and spirometric assessment.
• A Genome Sequence for the Threatened Whitebark Pine Tue, 28 Nov 2023 06:00:00 -0500
  Whitebark pine (WBP, Pinus albicaulis ) is a white pine of subalpine regions in western contiguous US and Canada. WBP has become critically threatened throughout a significant part of its natural range due to mortality from the introduced fungal pathogen white pine blister rust (WPBR, Cronartium ribicola ) and additional threats from mountain pine beetle ( Dendroctonus ponderosae ), wildfire, and maladaptation due to changing climate. Vast acreages of WBP have suffered nearly complete mortality....
• Atrial fibrosis heterogeneity is a risk for atrial fibrillation in pigs with ischaemic heart failure Tue, 28 Nov 2023 06:00:00 -0500
  CONCLUSION: Our results suggest that left atrial cross-regional fibrosis difference rather than overall fibrosis level is associated with IHF-related AF susceptibility, presumably by establishing local conduction disturbances and heterogeneity.
• Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study Mon, 27 Nov 2023 06:00:00 -0500
  Understanding the development of humoral immune responses of children and adolescents to SARS-CoV-2 is essential for designing effective public health measures. Here we examine the changes of humoral immune response in school-aged children and adolescents during the COVID-19 pandemic (June 2020 to July 2022), with a specific interest in the Omicron variant (beginning of 2022). In our study "Ciao Corona", we assess in each of the five testing rounds between 1874 and 2500 children and adolescents...
• Functional connectivity in autism spectrum disorder evaluated using rs-fMRI and DKI Mon, 27 Nov 2023 06:00:00 -0500
  We evaluated functional connectivity (FC) in patients with adult autism spectrum disorder (ASD) using resting-state functional MRI (rs-fMRI) and diffusion kurtosis imaging (DKI). We acquired rs-fMRI data from 33 individuals with ASD and 33 healthy controls (HC) and DKI data from 18 individuals with ASD and 17 HC. ASD showed attenuated FC between the right frontal pole (FP) and the bilateral temporal fusiform cortex (TFusC) and enhanced FC between the right thalamus and the bilateral inferior...
• Development and validation of prediction models for poor sleep quality among older adults in the post-COVID-19 pandemic era Mon, 27 Nov 2023 06:00:00 -0500
  CONCLUSIONS: This nomogram, based on twelve-variable, could potentially serve as a practical and reliable tool for early identification of poor sleep quality among older adults during the post-pandemic period.
• New predictive biomarkers for screening COVID-19 patients with rhabdomyolysis in combination with cystatin C Mon, 27 Nov 2023 06:00:00 -0500
  CONCLUSION: CysC is an essential evaluation indicator for COVID-19 patients' prognosis. AST*CysC and LDH*CysC have superior predictive value to CysC for SKM, RM, and death, and optimal classification for RM.
• Radiation exposure and gender issues in interventional cardiology laboratories in Italy Mon, 27 Nov 2023 06:00:00 -0500
  No abstract
• Interaction of TiO₂ nanoparticles with lung fluid proteins and the resulting macrophage inflammatory response Mon, 27 Nov 2023 06:00:00 -0500
  Inhalation is a major exposure route to nanoparticles. Following inhalation, nanoparticles first interact with the lung lining fluid, a complex mixture of proteins, lipids, and mucins. We measure the concentration and composition of lung fluid proteins adsorbed on the surface of titanium dioxide (TiO(2)) nanoparticles. Using proteomics, we find that lung fluid results in a unique protein corona on the surface of the TiO(2) nanoparticles. We then measure the expression of three cytokines...